Speaker: Mohamed S. Bouzidi PhD, Postdoctoral Researcher, Pillai Lab, Vitalant Research Institute
Mohamed (Salah) Bouzidi is a post-doctoral researcher in Satish Pillai lab at Vitalant Research Institute in San Francisco. During his doctoral thesis work at the Pasteur Institute of Paris, he studied the role of the APOBEC3 cytidine deaminases in the context of Hepatitis B Virus infection as well as in cancer, unveiling the role of the cytidine deaminase APOBEC3DE in the context of HBV infection. At VRI, Mohamed is focusing on CRISPR-Cas9 approaches to knock out HIV provirus and render cells refractory to HIV infection.
In this webinar, he covers the work he has been doing on targeting HIV provirus and HIV receptors simultaneously using CRISPR-Cas9 and single cell sequencing to evaluate editing efficiency and co-editing occurrences.
Offered Free by: Thermo Fisher
See All Resources from: Thermo Fisher
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.